Vivasure Medical
  • Home
  • About Us
  • Our Technology
    • PerQseal® Elite
    • Clinical Programme
  • Product Information
    • e-IFU
    • Implant Cards
      • PerQseal Elite
  • News
  • Contact
Select Page

Mark McGoldrick

By: jonadmin|Published on: Oct 22, 2025|Categories: Management|

Recent Posts

  • Haemonetics Acquires Vivasure Medical Limited
  • Vivasure Medical Submits PMA Application for PerQseal® Elite and Secures Expanded Venous Indication in Europe
  • Vivasure Medical Receives CE Mark Approval in Europe for PerQseal Elite Vascular Closure System
  • Vivasure Announces Positive Results of PATCH IDE Pivotal Study Indicating Safety and Efficacy of PerQseal® Large Hole Closure Device
  • TCT 2024: Vivasure Medical to Unveil US Pivotal Data for PerQseal® Elite Vascular Closure System

Recent Comments

No comments to show.
CiPRO
General Enquiries:  t: +353 91 395440  f: +353 91 395 399  e: info@vsuremed.com
Customer Service: t: +31 73 3035511  f: + 31 73 3690583  e: vivasure@healthlinkeurope.com

General Enquiries:
t: +353 91 395440
f: +353 91 395 399
e: info@vsuremed.com

Customer Service:
t: +31 73 3035511
f: + 31 73 3690583
e: vivasure@healthlinkeurope.com

Vivasure Medical Limited, Parkmore Business Park West, Galway, Ireland, H91 V3KP

Copyright © Vivasure Medical – All rights reserved|Developed by Eiger Creative Ltd.
PerQseal® and Vivasure Medical® are registered trademarks of Vivasure Medical Ltd.
Terms and conditions  | Privacy Statement
PerQseal®ELITE is CE Mark approved. Not available for sale in the United States.

  • Follow